Several studies have shown that ZBTB4 is downregulated in multiple tumor types, such as breast cancer, Ewing sarcoma, and colorectal cancer (Kim et al., 2012; Yu et al., 2018; Xiang et al., 2020). This evidence concerns the gene ZBTB4 and breast carcinoma.